SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Osprey who wrote (1079)10/13/2000 10:17:06 AM
From: Ian@SI  Read Replies (1) of 1321
 
O.,

So you more than anyone else understands the inherent value

Not really. There's 0.5M new families every year that have been witnessing the devastating impact that this disease has on people, their ability to fully enjoy life, and, their ability to maintain independence. And that includes Julia Levy's own mother.

Prior to Visudyne, some barbaric retinal specialists actually burned a hole through the macula, immediately destroying some vision, hoping to stop the abnormal blood vessels from causing further damage.

Any informed patient suffering from AMD will opt for Visudyne therapy, IMO. And no shoddy poll, by a house which may well have an undeclared vested interest, will change that fact.

FWIW,
Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News